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Abstract
Phenomics is the comprehensive study of phenotypes at every level of biology: from metabolites to organisms. With high
throughput technologies increasing the scope of biological discoveries, the field of phenomics has been developing rapid and
precise methods to collect, catalog, and analyze phenotypes. Such methods have allowed phenotypic data to be widely used in
medical applications, from assisting clinical diagnoses to prioritizing genomic diagnoses. To channel the benefits of phenomics
into the field of inborn errors of metabolism (IEM), we have recently launched IEMbase, an expert-curated knowledgebase of
IEM and their disease-characterizing phenotypes. While our efforts with IEMbase have realized benefits, taking full advantage of
phenomics requires a comprehensive curation of IEM phenotypes in core phenomics projects, which is dependent upon contri-
butions from the IEM clinical and research community. Here, we assess the inclusion of IEM biochemical phenotypes in a core
phenomics project, the Human Phenotype Ontology. We then demonstrate the utility of biochemical phenotypes using a text-
based phenomics method to predict gene-disease relationships, showing that the prediction of IEM genes is significantly better
using biochemical rather than clinical profiles. The findings herein provide a motivating goal for the IEM community to expand
the computationally accessible descriptions of biochemical phenotypes associated with IEM in phenomics resources.
Keywords Biochemical phenotypes .Metabolic phenotypes .Clinical informatics . Text-basedphenomics .Datamining . Inborn
errors of metabolism
Introduction
Patient phenotyping marks the beginning of the fundamental
process of clinical genetics: uncovering the genetic etiology of
the disease. The rate of genetic discovery has been accelerated
by the adoption of genome-wide sequencing, and continues to
generate an explosive amount of compiled phenotypic and
genetic information (Chong et al 2015; Amberger et al
2011). Such abundance is motivating increasingly sophisticat-
ed efforts to (i) define a new phenotype and (ii) distinguish a
novel phenotype from an existing one (Biesecker 2004;
Amberger et al 2011). Therefore, both the scientific and clin-
ical communities have focused on the acquisition of precise
and comprehensive phenotypic data, or Bphenomics^
(Brunner and van Driel 2004; Houle et al 2010; Hennekam
and Biesecker 2012; Robinson 2012; Deans et al 2015).
Scientifically, the word Bphenome^ refers to the entirety of
observable traits from all levels of the biological hierarchy:
from metabolites to organisms (Houle et al 2010). Clinically,
the word refers to a collection of morphological,
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physiological, and behavioral characteristics observed in a
patient (Robinson 2012). In either context, the field has seen
numerous developments of large-scale projects (Houle et al
2010; Amberger et al 2015; Mungall et al 2017; Blake et al
2017). A successful example of such is the widely used
Human Phenotype Ontology (HPO), which provides a stan-
dardized vocabulary of abnormal phenotypes observed in hu-
man diseases (Köhler et al 2017). HPO illustrates the value
and motivation behind phenomics: (i) it enables accurate and
consistent description of phenotypes, and (ii) it enables com-
putational assessment of similarity between phenotypes
(Köhler et al 2017). Based on the two attributes, HPO has
become a foundation for computational methods that collect
(Girdea et al 2013), catalog (Mungall et al 2017), share
(Gottlieb et al 2015; Philippakis et al 2015), and analyze
(Köhler et al 2009) phenotypic data. Furthermore, it has been
demonstrated that precise, comprehensive profiling and anal-
ysis of phenotypes using HPO can augment clinical exome/
genome sequencing data interpretation (Bone et al 2016;
Sifrim et al 2013; Smedley and Robinson 2015).
However, phenomics has not yet been fully exploited in
some domains of rare genetic diseases (Boycott et al 2017;
Köhler et al 2017). Inborn errors of metabolism (IEM)
exemplify one such domain (Köhler et al 2017). Caused
by genetic defects in metabolism, IEM represent the largest
group of monogenetic defects that are amenable to targeted
treatments (Tarailo-Graovac et al 2016). They present dis-
tinct biochemical phenotypes and a heterogeneous array of
clinical symptoms (Burton 1998). This characteristic has
motivated the IEM clinical and research community to
document both clinical and biochemical aspects of IEM
(Lee et al 2017). Meanwhile, recent developments in
phenomics have focused primarily on clinical aspects
(Köhler et al 2017), resulting in an underrepresentation of
biochemical phenotypes that may have slowed the uptake
of phenomics by the IEM community. Moreover, deep phe-
notyping has become increasingly important for IEM as
genome-wide sequencing identifies a growing number of
cases with two distinct genetic diseases that present blend-
ed phenotypes (Tarailo-Graovac et al 2016). To address
this gap, we created IEMbase, an expert-curated
knowledgebase of IEM and their phenotypes (Lee et al
2017). However, our efforts only partially fill the gap,
and the need for concurrent curation of IEM phenotypes
in core phenomics projects remains.
Thus, we assessed the curation status of IEM phenotypes in
HPO in comparison with IEMbase.We then extracted disease-
characterizing phenotypic data from IEMbase and demon-
strated their utility in diagnostic applications of phenomics
using a text-based method that prioritizes compatible genetic
diagnoses. We hope the findings presented herein catalyze
community-wide participation to accelerate the cataloging of
IEM phenotypes in IEMbase and HPO.
Methods
Themethods presented herein require a distinction between bio-
chemical and clinical phenotypes of IEM. We define biochem-
ical phenotypes as biochemical abnormalities that are observable
by laboratory investigations. We define clinical phenotypes as
morphological, (patho-)physiological, developmental, and be-
havioral abnormalities observable by clinical examinations.
Assessment of biochemical phenotype
curation in HPO and IEMbase
We previously compiled the clinical aspect of IEM and ex-
plored their representation within HPO (Lee et al 2017).
Therefore, only the biochemical aspect of IEM was the focus
of this effort. In the aforementioned study, we were not able to
map biochemical phenotypes in IEMbase to HPO due to the
stringent criteria requiring exact character-by-character
matches. Based on this knowledge, the comparison presented
herein used relaxed criteria.
For this assessment, a complete list of phenotypes in HPO
was downloaded from the HPO website (http://human-
phenotype-ontology.github.io) in OBO format (version:
2017–06-30 release). Using the ontologyIndex R package
(Greene et al 2017) (R version 3.4.0), the OBO file was
parsed, and all phenotypes and their synonyms pertaining to
Bphenotypic abnormality (HP:0000118)^ were extracted (n =
37,732). In parallel, a complete list of phenotypes in IEMbase
was downloaded from the IEMbase server (version: 1.1.0) in
CSV format. The downloaded list contained 1151 biochemi-
cal phenotypes and 1231 clinical phenotypes. Only the bio-
chemical phenotypes were extracted for the assessment.
Before comparing the two, differences in alphabetic case,
singular/plural variants, punctuation, stop words, and word
order were removed using the Norm program in the
SPECIALIST Lexical Tools (Browne et al 2003). The HPO
phenotypes were then compared against the IEMbase pheno-
types using a custom script written in Ruby programming
language. A match was declared only if the name of a HPO
phenotype had an exact match or it completely contained the
name of an IEMbase phenotype. As an example of the latter,
the HPO phenotype Belevated urinary homovanillic acid (HP:
0011977)^ was considered a match for the IEMbase pheno-
type Bhomovanillic acid^ since the HPO phenotype contained
both the word Bhomovanillic^ and the word Bacid^. After the
computational comparison, the phenotype matches were
reviewed manually. The mappings were then grouped by their
membership in the 26 subclasses of the HPO class
Bphenotypic abnormality (HP:0000118)^. A detailed list of
the 26 subclasses is provided in Fig. 1. Finally, the grouped
mappings were visualized in a Circos plot using the circlize R
package (Gu et al 2014).
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Text-based phenotype analysis
for prioritization of causal genes
Figure 2 illustrates the analysis procedure. Five hundred sixty-
three disease-gene pairings (or Bpairs^) and their phenotypic
descriptions (or Bprofiles^) were downloaded from the
IEMbase server (version: 1.1.0). An example disease-gene
pair and its phenotypic profile are provided in Table 1. In order
to apply the text-based phenotype analysis described in the
next paragraph, the phenotypes in each profile were equated
to the corresponding terms in the Unified Medical Language
System (UMLS) (https://www.nlm.nih.gov/research/umls)
using the UMLS REST API (https://documentation.uts.nlm.
nih.gov/rest/home.html). For clarity, the mapping between
IEMbase and HPO from the earlier section does not relate to
the mapping exercise described herein.
Each phenotypic profile was analyzed using a text-based
method that was originally developed for variant prioritization
in clinical exome interpretation (Gottlieb 2017). Briefly, the
method accepts a set of phenotype terms and returns a ranked
list of genes. The ranking was calculated based on information
reported by a text analysis system (Lever et al 2017). For our
analysis, the procedure was performed as follows. A disease-
gene pair d was selected from the set of all IEMbase disease-
gene pairs D = {d1, d2,…, dn}. Within IEMbase d was
coupled to a phenotypic profile P, which contained a set of
phenotypes {p1, p2,…, pr} as illustrated in Table 1. The
method then predicted associated genes for P from the ge-
nome G = {g1, g2,…, gm} which was defined as all genes
pertaining to the UMLS semantic type Bgene or genome
(T028)^. For each g ∈G, the strength of its association with
P (denoted by sg, P) was determined as a sum of individual
association scores between g and pi. The individual associa-
tion score was calculated as the ratio of the number of
sentences where g and pi appeared together over the total
number of sentences where g and pi appeared individually
(where these values were obtained from the text analysis tool
(Lever et al 2017)). Each gene g was ranked according to sg, P
and the top 100 phenotype P-associated genes were retained
before the method continued on to the next disease d ∈D.
For each d, the top 100 associated gene predictions were
obtained using the method outlined above, and the rank of d’s
causal gene gd in the top 100 predictions was determined. To
assess the performance of the text-based method, the ranking
of all causal genes Gd ¼ gd1 ; gd2 ;…; gdn
 
was compared
against the baseline ranking of Gd. The baseline ranking was
defined as the median ranking of each gd ∈Gd, which was
determined by taking the median of gd’s ranks in the predic-
tions for d ∈D that gd did not have a causal relationship with.
Furthermore, the effect of the number of phenotypes spec-
ified for each d ∈D on its causal gene prediction was evaluat-
ed by testing their correlation. This test was restricted to only
d ∈D whose causal gene gd was ranked within the top 100
predictions.
Fig. 1 An overview of HPO to IEMbase mapping. 287 biochemical
phenotypes in IEMbase had 852 associations with 475 unique HPO
phenotypes. The figure illustrates such mappings with respect to 26
subclasses of the HPO class Bphenotypic abnormality (HP:0000118)^.
BMultiple subclasses^ refer to HPO phenotypes that belong to multiple
subclasses, consisting of: abnormality of metabolism/homeostasis
(HP:0001939), abnormality of the genitourinary system (HP:0000119),
abnormality of the endocrine system (HP:0000818), abnormality of the
nervous system (HP:0000707), abnormality of blood and blood-forming
tissues (HP:0001871), abnormality of the immune system (HP:0002715),
and abnormality of the digestive system (HP:0025031)
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In addition, we assessed the impact of biochemical pheno-
types for the disease gene prediction compared with clinical
phenotypes. For this, the set of phenotypes P for each d ∈D
was divided into biochemical and clinical subsets, and each
subset was then analyzed using the aforementioned text-based
method to predict the top 100 associated genes. Finally, a
comparison was made between the ranks of causal genes de-
termined using biochemical phenotypes and the ranks deter-
mined using clinical phenotypes.
Results
Comparison of curated biochemical phenotypes
between HPO and IEMbase
The curated IEMbase (v. 1.1.0) provides a total of 1151 bio-
chemical phenotypes, of which only 287 could be mapped
onto HPO. These 287 IEMbase biochemical phenotypes had
852 associations with 475 unique HPO phenotypes, indicating
a one-to-many relationship between IEMbase and HPO.
Figure 1 provides a visual overview of these mappings, which
highlights the IEMbase biochemical phenotypes that map
most commonly onto the HPO metabolism category
(HP:0001939) (420 mappings to 219 unique phenotypes). A
survey of 864 unmapped IEMbase biochemical phenotypes
revealed that the majority were complex names, such as B7-
alpha-hydroxy-3-oxo-cholenoic acids^. These unmapped
phenotypes will be submitted to HPO for consideration for
future inclusion.
Evaluation of phenotype-associated gene predictions
by text-based phenotype analysis
Using all phenotypes (biochemical and clinical), the text-based
phenotype analysis prioritized correct genetic diagnoses for
120 out of 563 disease-gene pairs within the top ten predictions
and 173 out of 563 disease-gene pairs within the top 20 predic-
tions (Table 2). This performance was statistically assessed by
comparing the causal gene ranking against the baseline ranking
using the McNemar’s test (mcnemar.exact implemented by
exact2x2 R package; Fay 2010) with the Bonferroni correction.
A dichotomous trait for the McNemar’s test was defined as (1)
disease-gene pairs whose causal genes ranked within the top N
predictions or (2) disease-gene pairs whose causal genes did
not rank within the top N predictions where N = 1, 5, 10, 20,
100. This assessment confirmed that the method placed causal
genes within the top N predictions significantly more often than
the baseline (Table 2). However, the method’s performance
appeared to be limited as diagnoses for 255 disease-gene pairs
were not found within the top 100 predictions (Table 2). This
may be due to the inconsistent depth of literature on genes
limiting the performance of the recommendation system aswell
as the lack of semantic representation in sentence-level co-oc-
currence. As an example of the latter, if a sentence in a publi-
cation described that Bmutations in the gene PAH cause elevat-
ed blood phenylalanine^, then the phenotype-gene association
Fig. 2 An illustration of the text-based phenotype analysis procedure.
Numbered boxes (in orange) represent the main steps of the text-based
phenotype analysis. First, 563 disease-gene pairings were extracted from
IEMbase (v. 1.1.0). Each pair contained the disorder name and gene
name, and the pair was coupled to a phenotypic profile (i.e., disease
symptoms and biomarkers). Second, using the phenotypic profile P, as-
sociated genes were identified using a text-analysis tool by Lever et al.
The association strength between P and g was defined as the ratio of the
number of sentences in the PubMed literature where P and g appeared
together over the total number of sentences where P and g appeared
individually. Third, the identified genes were ranked by the strength of
their association with P before a list of top 100 associated genes was
determined. Finally, the causal gene gd was identified based on the
disease-gene pair connected to P. The rank of gd was recorded
Table 1 An example disease-gene pair and its phenotypic profile ex-
tracted from IEMbase
Disease name Dopamine beta-hydroxylase deficiency
Associated gene DBH
Phenotypes* Exercise intolerance
Hypoglycemia
Hypotension, orthostatic
Dopamine (plasma)
Epinephrine (plasma)
Homovanillic acid, HVA (cerebrospinal fluid)
Vanillinmandelic acid, VMA (urine)
*Only select phenotypes are listed for brevity
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was established based only on the co-occurrence of the words
BPAH^ and Bphenylalanine^ and not based on the fact that
Bphenylalanine^ was Belevated^ due to a defect in BPAH^.
Meanwhile, there was no significant effect on the caus-
al gene predictions made by the number of phenotypes
specified for the disease-gene pairs (p = 0.15; cor. test on
Spearman’s correlation in R; Fig. S1 in Supplemental
material).
In the evaluation of the impact on gene predictions by
biochemical phenotypes versus clinical phenotypes, signifi-
cantly more causal genes were predicted within the top N
predictions (N = 1, 5, 10, 20, 100) using biochemical pheno-
types than clinical phenotypes (Table 3; McNemar’s test with
Bonferroni correction). This result may suggest that the asso-
ciation between biochemical phenotypes and IEM genes are
likely more represented in the current literature than clinical
phenotypes and IEM genes. Figure 3 illustrates the difference
in gene prediction performance between the two subsets of
phenotypes.
Discussion
In this report, we explored and extended the utility of curated
disease annotations for IEM for the emerging age of
phenomics analysis. We assessed the overlap between bio-
chemical phenotypes compiled by curators of IEMbase and
all phenotypes within the HPO, noting limited coverage. We
demonstrated that the use of biochemical phenotypes can sig-
nificantly improve the prediction of gene-disease relationships
for IEM, compared to clinical phenotypes, using text-based
phenotype analysis.
The comparison of curated biochemical phenotypes be-
tween IEMbase and HPO revealed that only 25% of the bio-
chemical phenotypes in IEMbase could be mapped to HPO.
Incomplete mapping could arise for a number of reasons. For
instance, (1) a HPO phenotype may not share the exact word-
ing of the synonymous IEMbase phenotypes or (2) a more
general HPO phenotype may refer to one or more specific
IEMbase phenotypes. This suggests that future curation could
Table 2 A summary of text-
based phenotype analysis
performance
N Top 1 Top 5 Top 10 Top 20 Top 100
Number of disease-gene pairs ranked
within top N predictions
(% success at N)a
31
(5.5)
90
(16.0)
120
(21.3)
173
(30.7)
308
(54.7)
McNemar’s test at N
(causal vs baseline) b
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
a%Success at N refers to the proportion of IEMbase disease-gene pairs whose causal genes ranked within the top
N predictions
bMcNemar’s test at N refers to paired comparison between the causal ranking and the baseline ranking with a
dichotomous trait defined as (1) disease-gene pairs whose causal genes ranked within the top N predictions or (2)
disease-gene pairs whose causal genes did not rank within the top N predictions where N = 1, 5, 10, 20, 100.
Reported p-value was adjusted using the Bonferroni correction
Table 3 An overview of impact
on gene predictions by
biochemical phenotypes vs
clinical phenotypes
N Top 1 Top 5 Top 10 Top 20 Top 100
Number of disease-gene pairs ranked within
top N predictions based on biochemical
phenotypes
(% success at N)a
19
(3.4)
67
(11.9)
88
(15.6)
132
(23.4)
292
(51.9)
Number of disease-gene pairs ranked within
top N predictions based on clinical
phenotypes
(% success at N)a
2
(0.4)
12
(2.1)
22
(3.9)
37
(6.6)
132
(23.4)
McNemar’s test at N
(biochemical vs clinical) b
p = 0.0011 p < 0.001 p < 0.001 p < 0.001 p < 0.001
*Success at N refers to the proportion of IEMbase disease-gene pairs whose causal gene ranked within the top N
predictions
bMcNemar’s test at N refers to paired comparison between the biochemical ranking and the clinical rankingwith a
dichotomous trait defined as (1) genes ranked within the top N predictions or (2) genes not rankedwithin the top N
predictions where N = 1, 5, 10, 20, 100. Reported p-value was adjusted using the Bonferroni correction
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significantly improve phenotype mapping, and contributions
from the IEM clinical and research community would prove
instrumental to increasing the utility of available phenotypic
data. In addition, a collaboration between IEMbase and HPO
to include missing terms can contribute to improved coverage
of biochemical phenotypes in HPO.
The text-based phenotype analysis using all (biochemi-
cal and clinical) phenotypes revealed that genetic diagno-
ses for 31% of input disease-gene pairs could be success-
fully prioritized within the top 20 predictions. This number
is too low for immediate diagnostic utility. However, map-
ping patient phenotypes to candidate genes would normal-
ly consider a richer set of information than just phenotypic
descriptions. For example, in clinical exome/genome se-
quencing a comprehensive patient profile is constructed
based on both clinical and laboratory investigations before
prioritizing and interpreting a small set of genes containing
genetic alterations (Tarailo-Graovac et al 2016; Bone et al
2016; Smedley and Robinson 2015). Therefore, the diag-
nostic utility of phenotypic data lies in its synergy with
different investigative tools rather than its lone capacity to
assist diagnoses.
The evaluation of text-based disease gene predictions showed
better performance when incorporating biochemical phenotypes
compared to clinical phenotypes. This difference could be ex-
plained by the non-specific and heterogeneous nature of clinical
phenotypes of IEM (Leonard andMorris 2006). Such limitations
have been recognized by the IEM community and have motivat-
ed the extensive use of biochemical tests in diagnoses (Tebani
et al 2016). Given the IEM community’s emphasis on biochem-
ical phenotypes, finding ways to accelerate the compilation of
such annotations in IEMbase and to extend the inclusion of bio-
chemical phenotypes in HPO are important in the near term to
fully benefit from emerging advances in phenomics. An expand-
ed curation of phenotypes in HPO can improve recognition of
heterogeneous disease presentations and overlapping phenotypes
in text-based phenotype analyses, as the performance of such
methods are limited by the availability of curated disease anno-
tations. In the future, as HPO expands, curation efforts can pro-
vide greater granularity of biochemical phenotypes by
Fig. 3 Distribution of ranks using only biochemical phenotypes vs using
only clinical phenotypes. The x-axis represents the subset of phenotypes
(biochemical-only and clinical-only). The y-axis represents the ranks of
causal genes in the top N predictions. The distribution of ranks is shown
in a violin plot (hour-glass figure). A scatter plot version of the same
distribution (dot) is overlaid on top of the violin plot to show the position
of each data point in the distribution. The text-based method predicted
significantly more causal genes within the top N predictions (N = 1, 5, 10,
20, 100) using biochemical phenotypes than clinical phenotypes (Table 3;
McNemar’s test with Bonferroni correction)
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incorporating either continuous measurements or levels relative
to clinical decision criteria.
For readers who would like to contribute to data curation,
IEMbase accepts submissions of new or expanded IEM phe-
notypes, as well as edit requests to currently curated informa-
tion, via the project website (http://iembase.org/app). HPO
accepts new term submissions via an issue tracker available
on Github (https://github.com/obophenotype/human-
phenotype-ontology/issues). To submit a term to HPO,
please consult the submission guideline (https://github.com/
obophenotype/human-phenotype-ontology/wiki/How-to-
make-a-good-term-request) and create an issue using the
BNew issue^ button on the issue tracker page.
In summary, there is synergistic utility in phenotypic
data of IEM and phenomics methods that could be
harnessed by a multitude of diagnostic methods. With
the imminent shift toward a holistic clinical investigation
using multi-omics technologies (such as metabolomics,
lipidomics, and glycomics), we believe that a comprehen-
sive knowledgebase of phenotypes will serve as the basis
upon which different layers of data are integrated. Before
realizing such a role, however, the knowledgebase must
ensure complete incorporation of HPO into its structure in
order to accommodate the complexity of the upcoming
big phenotypic data. As such, community-wide efforts
for curation of biochemical phenotype data should be rec-
ognized as a critical step toward precision medicine.
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